PsychRounds: The Psychiatry Podcast podcast

VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austeo)

0:00
17:19
Rewind 15 seconds
Fast Forward 15 seconds

Welcome back! Today we are featuring the two FDA-approved medications for tardive dyskinesia, the VMAT2 inhibitors Valbenazine (Ingrezza) and Deutetrabenazine (Austedo).


References:

https://pubmed.ncbi.nlm.nih.gov/41626799/

https://www.ncbi.nlm.nih.gov/books/NBK548187/

https://pubmed.ncbi.nlm.nih.gov/41626799/


More episodes from "PsychRounds: The Psychiatry Podcast"